Pnc Financial Services Group, Inc. Codexis, Inc. Transaction History

Pnc Financial Services Group, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$1.5 - $3.75 $11,880 - $29,700	-7,920 Reduced 98.84%	93 $0
Q2 2023 Aug 11, 2023	BUY	$2.21 - $4.43 $17,708 - $35,497	8,013 New	8,013 $22,000
Q4 2022 Feb 10, 2023	BUY	$4.26 - $6.84 $9,282 - $14,904	2,179 Added 535.38%	2,586 $12,000
Q3 2022 Nov 10, 2022	BUY	$6.06 - $12.86 $2,466 - $5,234	407 New	407 $2,000
Q2 2022 Aug 12, 2022	SELL	$8.35 - $21.89 $8,266 - $21,671	-990 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$16.97 - $31.93 $1,493 - $2,809	88 Added 9.76%	990 $20,000
Q4 2021 Feb 11, 2022	SELL	$25.61 - $41.78 $947 - $1,545	-37 Reduced 3.94%	902 $28,000
Q3 2021 Nov 05, 2021	BUY	$19.65 - $27.99 $16,230 - $23,119	826 Added 730.97%	939 $21,000
Q4 2020 Feb 12, 2021	BUY	$11.7 - $23.41 $1,170 - $2,341	100 Added 769.23%	113 $2,000
Q2 2020 Aug 07, 2020	BUY	$9.8 - $12.77 $127 - $166	13 New	13 $0
Q1 2020 May 08, 2020	SELL	$8.78 - $18.6 $280 - $595	-32 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$13.12 - $17.06 $419 - $545	32 New	32 $0

125

59.9M

25.9K

20.1K

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $335M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.